Skip to main content
. 2016 Jan 6;2:15023. doi: 10.1038/npjbcancer.2015.23

Table 2. Multivariable Cox proportional hazard models of RFS and OS.

Variable (contrast) Recurrence-free survival
Overall survival
  Hazard ratio P-value Hazard ratio P-value
Number of positive nodes (sqrt) 2.17 (1.82, 2.60) <0.0001 2.18 (1.82, 2.63) <0.0001
Menopausal status (pre/post) 0.91 (0.75, 1.10) 0.3276 0.88 (0.72, 1.08) 0.2284
Dose density (q3wk/q2wk) 1.20 (0.99, 1.45) 0.0582 1.15 (0.94, 1.40) 0.1671
Sequence of therapy (con/seq) 0.98 (0.81, 1.18) 0.8314 0.98 (0.80, 1.19) 0.8174
 
PAM50 intrinsic subtype
 Basal-like versus LumA 1.83 (1.40, 2.38) <0.0001 1.91 (1.44, 2.53) <0.0001
 HER2-E versus LumA 1.63 (1.24, 2.15) 1.69 (1.27, 2.26)  
 LumB versus LumA 1.47 (1.14, 1.91) 1.47 (1.12, 1.94)

Abbreviations: con, concurrent; HER2-E, HER2-enriched; Lum, luminal; q2wk, every two weeks or 2-weekly; q3wk, every 3 weeks or 3-weekly; seq, sequential; sqrt, square root.

N=1,299 because 11 patients were missing information about the number of positive nodes or menopausal status.